Cite
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments.
MLA
Bouzid, Donia, et al. “Respiratory Syncytial Virus in Adults with Comorbidities: An Update on Epidemiology, Vaccines, and Treatments.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, no. 12, Dec. 2023, pp. 1538–50. EBSCOhost, https://doi.org/10.1016/j.cmi.2023.08.028.
APA
Bouzid, D., Visseaux, B., Ferré, V. M., Peiffer-Smadja, N., Le Hingrat, Q., & Loubet, P. (2023). Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 29(12), 1538–1550. https://doi.org/10.1016/j.cmi.2023.08.028
Chicago
Bouzid, Donia, Benoit Visseaux, Valentine Marie Ferré, Nathan Peiffer-Smadja, Quentin Le Hingrat, and Paul Loubet. 2023. “Respiratory Syncytial Virus in Adults with Comorbidities: An Update on Epidemiology, Vaccines, and Treatments.” Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 29 (12): 1538–50. doi:10.1016/j.cmi.2023.08.028.